Meeting of the National Vaccine Advisory Committee, 1868 [2014-00176]

Download as PDF 1868 Federal Register / Vol. 79, No. 7 / Friday, January 10, 2014 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Vaccine Advisory Committee Department of Health and Human Services, Office of the Secretary, Office of the Assistant Secretary for Health. ACTION: Notice of meeting. AGENCY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold a meeting. The meeting is open to the public. Preregistration is required for both public attendance and comment. Individuals who wish to attend the meeting and/or participate in the public comment session should register at https:// www.hhs.gov/nvpo/nvac, email nvpo@ hhs.gov, or call 202–690–5566 and provide name, organization, and email address. SUMMARY: The meeting will be held on February 11–12, 2014. The meeting times and agenda will be posted on the NVAC Web site at https://www.hhs.gov/ nvpo/nvac as soon as they become available. DATES: U.S. Department of Health and Human Services, Hubert H. Humphrey Building, Room 800, 200 Independence Avenue SW., Washington, DC 20201. FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, U.S. Department of Health and Human Services, Room 715–H, Hubert H. Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: (202) 690–5566; Fax: (202) 690– 4631; email: nvpo@hhs.gov. SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public Health Service Act (42 U.S.C. 300aa–1), the Secretary of Health and Human Services was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. The National Vaccine Advisory Committee was established to provide advice and make recommendations to the Director of the National Vaccine Program on matters related to the Program’s responsibilities. The Assistant Secretary for Health serves as Director of the National Vaccine Program. The topics to be discussed at the NVAC meeting will include presentations addressing the first annual mstockstill on DSK4VPTVN1PROD with NOTICES ADDRESSES: VerDate Mar<15>2010 16:40 Jan 09, 2014 Jkt 232001 report of progress on the National Vaccine Plan; adult immunizations, vaccine research, development, and innovation; vaccine financing, access to and supply of vaccines, and a report of the President’s Cancer Panel with a focus on HPV vaccination. In addition, NVAC working groups on Human Papillomavirus (HPV) Vaccine and Maternal Immunization will provide updates on the working groups’ progress. The meeting agenda will be posted on the NVAC Web site: https:// www.hhs.gov/nvpo/nvac prior to the meeting. Public attendance at the meeting is limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the National Vaccine Program Office at the address/phone listed above at least one week prior to the meeting. Members of the public will have the opportunity to provide comments at the NVAC meeting during the public comment periods on the agenda. Individuals who would like to submit written statements should email or fax their comments to the National Vaccine Program Office at least five business days prior to the meeting. Dated: January 6, 2014. Bruce Gellin, Director, National Vaccine Program Office, Executive Secretary, National Vaccine Advisory Committee. [FR Doc. 2014–00176 Filed 1–9–14; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Agency Information Collection Activities: Proposed Collection; Comment Request Agency for Healthcare Research and Quality, HHS. AGENCY: ACTION: Notice. This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) approve the proposed changes to the currently approved information collection project: ‘‘Medical Expenditure Panel Survey—Insurance Component.’’ In accordance with the Paperwork Reduction Act, 44 U.S.C. 3501–3521, AHRQ invites the public to comment on this proposed information collection. SUMMARY: PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 Comments on this notice must be received by March 11, 2014. ADDRESSES: Written comments should be submitted to: Doris Lefkowitz, Reports Clearance Officer, AHRQ, by email at doris.lefkowitz@AHRQ.hhs.gov. Copies of the proposed collection plans, data collection instruments, and specific details on the estimated burden can be obtained from the AHRQ Reports Clearance Officer. FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports Clearance Officer, (301) 427–1477, or by email at doris.lefkowitz@AHRQ.hhs.gov. SUPPLEMENTARY INFORMATION: DATES: Proposed Project Medical Expenditure Panel Survey— Insurance Component Employer-sponsored health insurance is the source of coverage for 85 million current and former workers, plus many of their family members, and is a cornerstone of the U.S. health care system. The Medical Expenditure Panel Survey—Insurance Component (MEPS– IC) measures the extent, cost, and coverage of employer-sponsored health insurance on an annual basis. Statistics are produced at the National, State, and sub-State (metropolitan area) level for private industry. Statistics are also produced for State and Local governments. The MEPS–IC was last approved by OMB on November 21st, 2013 and will expire on November 30th, 2016. The OMB control number for the MEPS–IC is 0935–0110. All of the supporting documents for the current MEPS–IC can be downloaded from OMB’s Web site at https:// www.reginfo.gov/public/do/ PRAViewDocument?ref_nbr=2013100935-001. In order to ensure that the MEPS–IC is able to capture important changes in the employer-sponsored health insurance market due to the implementation of the Patient Protection and Affordable Care Act (PPACA), AHRQ researched and proposed revisions to the 2014 survey questionnaires based on the law’s provisions. Many of these proposed revisions were related to the implementation of the Small Business Health Options Program (SHOP) exchanges/marketplaces that are available to small employers for purchasing health insurance beginning in 2014. The proposed revisions were sent to a variety of federal and private stakeholders to obtain their suggestions and comments. These stakeholders included the U.S. Department of Health and Human Services’ Assistant E:\FR\FM\10JAN1.SGM 10JAN1

Agencies

[Federal Register Volume 79, Number 7 (Friday, January 10, 2014)]
[Notices]
[Page 1868]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-00176]



[[Page 1868]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: Department of Health and Human Services, Office of the 
Secretary, Office of the Assistant Secretary for Health.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the National Vaccine Advisory Committee (NVAC) will hold a 
meeting. The meeting is open to the public. Pre-registration is 
required for both public attendance and comment. Individuals who wish 
to attend the meeting and/or participate in the public comment session 
should register at https://www.hhs.gov/nvpo/nvac, email nvpo@hhs.gov, or 
call 202-690-5566 and provide name, organization, and email address.

DATES: The meeting will be held on February 11-12, 2014. The meeting 
times and agenda will be posted on the NVAC Web site at https://www.hhs.gov/nvpo/nvac as soon as they become available.

ADDRESSES: U.S. Department of Health and Human Services, Hubert H. 
Humphrey Building, Room 800, 200 Independence Avenue SW., Washington, 
DC 20201.

FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, U.S. 
Department of Health and Human Services, Room 715-H, Hubert H. Humphrey 
Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: 
(202) 690-5566; Fax: (202) 690-4631; email: nvpo@hhs.gov.

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Health Service Act (42 U.S.C. 300aa-1), the Secretary of Health and 
Human Services was mandated to establish the National Vaccine Program 
to achieve optimal prevention of human infectious diseases through 
immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The National Vaccine Advisory Committee was 
established to provide advice and make recommendations to the Director 
of the National Vaccine Program on matters related to the Program's 
responsibilities. The Assistant Secretary for Health serves as Director 
of the National Vaccine Program.
    The topics to be discussed at the NVAC meeting will include 
presentations addressing the first annual report of progress on the 
National Vaccine Plan; adult immunizations, vaccine research, 
development, and innovation; vaccine financing, access to and supply of 
vaccines, and a report of the President's Cancer Panel with a focus on 
HPV vaccination. In addition, NVAC working groups on Human 
Papillomavirus (HPV) Vaccine and Maternal Immunization will provide 
updates on the working groups' progress. The meeting agenda will be 
posted on the NVAC Web site: https://www.hhs.gov/nvpo/nvac prior to the 
meeting.
    Public attendance at the meeting is limited to space available. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the National Vaccine Program Office at the address/phone listed 
above at least one week prior to the meeting. Members of the public 
will have the opportunity to provide comments at the NVAC meeting 
during the public comment periods on the agenda. Individuals who would 
like to submit written statements should email or fax their comments to 
the National Vaccine Program Office at least five business days prior 
to the meeting.

    Dated: January 6, 2014.
Bruce Gellin,
Director, National Vaccine Program Office, Executive Secretary, 
National Vaccine Advisory Committee.
[FR Doc. 2014-00176 Filed 1-9-14; 8:45 am]
BILLING CODE 4150-44-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.